Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

PLoS Medicine - United States
doi 10.1371/journal.pmed.0020313
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Enzastaurin Inhibits Tumours Sensitive and Resistant to Anti-Egfr Drugs

British Journal of Cancer
Cancer ResearchOncology
2008English

Transformation by Rat-Derived Oncogenic Retroviruses.

Microbiological Reviews
1981English

Benomyl Resistant Mutants of Schizosaccharomyces Pombe Cold-Sensitive for Mitosis

Current Genetics
MedicineGenetics
1982English

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights Into Differential Inhibitor Sensitivity

Cancer Cell
Cancer ResearchOncologyCell Biology
2007English

Oncogenic Transformation Induced by Membrane-Targeted Akt2 and Akt3

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Asbestos, Radiation and Oncogenic Transformation

British Journal of Cancer
Cancer ResearchOncology
1984English

Inhibitor SBFI26 Suppresses the Malignant Progression of Castration-Resistant PC3-M Cells by Competitively Binding to Oncogenic FABP5

Oncotarget
Oncology
2017English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery
Oncology
2014English

Thyroid C-Cell Biology and Oncogenic Transformation

Recent Results in Cancer Research
MedicineCancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy